Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Aug 1;98(2):E291-E298.
doi: 10.1002/ccd.29423. Epub 2020 Dec 14.

Transaxillary transcatheter ACURATE neo aortic valve implantation - The TRANSAX multicenter study

Affiliations
Multicenter Study

Transaxillary transcatheter ACURATE neo aortic valve implantation - The TRANSAX multicenter study

Ignacio J Amat-Santos et al. Catheter Cardiovasc Interv. .

Abstract

Background: Transcatheter aortic valve replacement (TAVR) via transaxillary (TAx) approach with ACURATE neo valve is an off-label procedure. Our aim was to gather information on ACURATE neo cases implanted via TAx approach and report major outcomes.

Methods and results: The TRANSAX Study (NCT04274751) retrospectively gathered patients from nine centres in Europe and North America treated with ACURATE neo valve through TAx approach up to May/2019. Follow up was pre-specified at 1-year and was obtained for all patients. A total of 75 patients (79 ± 10 years; 32% women) were included. Left axillary (72%) and conscious sedation (95.2%) were the most common setting. Risk scores were higher when right axillary artery and surgical cut-down were selected. Severe complications including valve embolization, coronary obstruction, annulus rupture, and procedural mortality did not occur. Cardiac tamponade occurred in two cases (2.7%) with one requiring conversion to open surgery (1.3%). Bail-out stenting and surgical vascular repair were required in 7 (9.3%) and 3 (4%) cases, respectively. The need for new permanent pacemaker was 8%. Procedural success (96%), in-hospital (2.7%), and 1-year mortality (8%) were comparable in all settings. Only one case (1.3%) complicated with cerebrovascular event and one (1.3%) presented moderate aortic regurgitation before discharge.

Conclusions: TAx TAVR procedures with the ACURATE neo valve were presented high success rate and low in-hospital and 1-year mortality.

Keywords: ACURATE neo; TAVI; TAVR; trans-subclavian; transaxillary.

PubMed Disclaimer

References

REFERENCES

    1. Brennan JM, Holmes DR, Sherwood MW, et al. The association of transcatheter aortic valve replacement availability and hospital aortic valve replacement volume and mortality in the United States. Ann Thorac Surg. 2014;98:2016-2022.
    1. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous trans- catheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case de-scription. Circulation. 2002;106:3006-3008.
    1. Kurra V, Schoenhagen P, Roselli EE, et al. Prevalence of significant peripheral artery disease in patients evaluated for percutaneous aortic valve insertion: Preproce- dural assessment with multidetector computed tomography. J Thorac Cardiovasc Surg. 2009;137:1258-1264.
    1. Caceres M, Braud R, Roselli EE. The axillary/subclavian artery access route for transcatheter aortic valve replacement: a systematic review of the literature. Ann Thorac Surg. 2012;93:1013-1018.
    1. Schofer N, Deuschl F, Conradi L, Lubos E, Schirmer J, Reichens- purner H, Blankenberg S, Treede H, Schäfer U. Preferential short cut or alternative route: the transaxillary access for transcatheter aortic valve implantation. J Thorac Dis 2015;7:1543-1547.

Publication types

LinkOut - more resources